Stock analysts at HC Wainwright boosted their Q3 2025 earnings per share (EPS) estimates for shares of Alnylam ...

Fintel reports that on April 7, 2025, HC Wainwright & Co. initiated coverage of Fold Holdings (NasdaqCM:FLD) with a Buy ...

Fintel reports that on April 7, 2025, HC Wainwright & Co. initiated coverage of Alto Neuroscience (NYSE:ANRO) with a Buy ...

HC Wainwright lifted their Q1 2025 EPS estimates for Spectral AI in a note issued to investors on Wednesday, April 2nd. HC ...

H.C. Wainwright analyst Patrick Trucchio initiated coverage of Alto Neuroscience (ANRO) with a Buy rating and $10 price target Alto is ...

H.C. Wainwright analyst Scott Buck lowered the firm’s price target on Knightscope (KSCP) to $12 from $16 and keeps a Buy rating on the shares.

Regulatory News: MaaT Pharma (EURONEXT: MAAT – the "Company"), a clinical-stage biotechnology company and a leader in the ...

Sarepta and Roche paused Elevidys trials in the EU after a patient death. Analysts warn of potential sales declines as safety concerns impact market outlook.

Fintel reports that on April 3, 2025, HC Wainwright & Co. initiated coverage of Kairos Pharma (NYSEAM:KAPA) with a Buy recommendation. As of April 2, 2025, the average one-year price target for ...

On Monday, H.C. Wainwright reaffirmed its Buy rating and $3.00 price target on RenovoRx Inc. (NASDAQ: RNXT) following the company’s strategic update and a fireside chat. With the stock currently ...